SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals informs about conference call

08 Jun 2026 Evaluate

Pursuant to Regulation 30 read with sub para 15, Para A Part A Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fredun Pharmaceuticals has informed that Company will host an Earnings Conference call on Wednesday, 10th June, 2026 at 11:00 am. Earnings Conference Call Dial-In Information is enclosed. 

The above information is a part of company’s filings submitted to BSE.  


Fredun Pharma Share Price

2297.80 -11.05 (-0.48%)
08-Jun-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.00
Dr. Reddys Lab 1275.00
Cipla 1390.00
Zydus Lifesciences 1086.85
Lupin 2252.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×